Tonix Pharmaceuticals Q3 2026 Earnings Preview

Tonix Pharmaceuticals (TNXP) is scheduled to announce Q3 earnings results on Monday, November 9th, before market open. - The consensus EPS estimate is -$2.24 and the consensus revenue estimate is $16.32M (vs. $3.29M in Q3 2025). - Over the last 3 months, EPS

Tonix Pharmaceuticals (TNXP) is scheduled to announce Q3 earnings results on Monday, November 9th, before market open. – The consensus EPS estimate is -$2.24 and the consensus revenue estimate is $16.32M (vs. $3.29M in Q3 2025). – Over the last 3 months, EPS

Leave a Reply

Your email address will not be published. Required fields are marked *